Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation.

Yang Q, Dong Y, Wu W, Zhu C, Chong H, Lu J, Yu D, Liu L, Lv F, Wang S.

Nat Commun. 2012;3:1206. doi: 10.1038/ncomms2209.

PMID:
23149750
2.

The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer.

Oyama K, Kawakami K, Maeda K, Ishiguro K, Watanabe G.

Anticancer Res. 2004 Mar-Apr;24(2B):649-54.

3.

CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma.

Jing F, Yuping W, Yong C, Jie L, Jun L, Xuanbing T, Lihua H.

Tumour Biol. 2010 Aug;31(4):321-31. doi: 10.1007/s13277-010-0040-x. Epub 2010 May 20.

PMID:
20490964
4.

Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.

Park SY, Kwon HJ, Choi Y, Lee HE, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH.

Mod Pathol. 2012 Feb;25(2):185-96. doi: 10.1038/modpathol.2011.160. Epub 2011 Oct 28.

5.

Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.

Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS.

Mod Pathol. 2006 Aug;19(8):1083-90. Epub 2006 May 12.

6.

Promoter CpG island hypermethylation during breast cancer progression.

Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH.

Virchows Arch. 2011 Jan;458(1):73-84. doi: 10.1007/s00428-010-1013-6. Epub 2010 Dec 1.

PMID:
21120523
7.

Progressive methylation during the serrated neoplasia pathway of the colorectum.

Dong SM, Lee EJ, Jeon ES, Park CK, Kim KM.

Mod Pathol. 2005 Feb;18(2):170-8.

8.

CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.

Kim YH, Petko Z, Dzieciatkowski S, Lin L, Ghiassi M, Stain S, Chapman WC, Washington MK, Willis J, Markowitz SD, Grady WM.

Genes Chromosomes Cancer. 2006 Aug;45(8):781-9.

PMID:
16708352
9.

Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers.

Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA.

Mol Cancer. 2008 Dec 31;7:94. doi: 10.1186/1476-4598-7-94.

10.

Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.

Konishi K, Shen L, Wang S, Meltzer SJ, Harpaz N, Issa JP.

Gastroenterology. 2007 Apr;132(4):1254-60. Epub 2007 Jan 25.

PMID:
17408633
11.

Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.

Kim JC, Choi JS, Roh SA, Cho DH, Kim TW, Kim YS.

Ann Surg Oncol. 2010 Jul;17(7):1767-76. doi: 10.1245/s10434-009-0901-y. Epub 2010 Jan 15.

PMID:
20077021
12.

DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis.

Kim TO, Park J, Kang MJ, Lee SH, Jee SR, Ryu DY, Yang K, Yi JM.

Int J Mol Med. 2013 May;31(5):1255-61. doi: 10.3892/ijmm.2013.1317. Epub 2013 Mar 26.

PMID:
23546389
13.

CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.

Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M.

Clin Cancer Res. 2006 May 15;12(10):2995-3002.

14.

Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.

Tanaka M, Chang P, Li Y, Li D, Overman M, Maru DM, Sethi S, Phillips J, Bland GL, Abbruzzese JL, Eng C.

Clin Cancer Res. 2011 Jul 1;17(13):4531-40. doi: 10.1158/1078-0432.CCR-10-0763. Epub 2011 May 6.

15.

Status and significance of CpG island methylator phenotype in endometrial cancer.

Zhang QY, Yi DQ, Zhou L, Zhang DH, Zhou TM.

Gynecol Obstet Invest. 2011;72(3):183-91. doi: 10.1159/000324496. Epub 2011 Sep 27.

PMID:
21968189
16.

RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.

Nishio M, Sakakura C, Nagata T, Komiyama S, Miyashita A, Hamada T, Kuryu Y, Ikoma H, Kubota T, Kimura A, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Ochiai T, Kokuba Y, Sonoyama T, Ida H, Ito K, Chiba T, Ito Y, Otsuji E.

Anticancer Res. 2010 Jul;30(7):2673-82.

PMID:
20682997
17.

Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia.

Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH.

Lab Invest. 2004 Jul;84(7):884-93.

18.

Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.

Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S, Wu CW, Wu WK, He M, Wang M, Ng SS, Sung JJ.

Oncogene. 2010 Dec 9;29(49):6464-74. doi: 10.1038/onc.2010.370. Epub 2010 Aug 30.

PMID:
20802524
19.

Analysis of promoter CpG island hypermethylation in cancer: location, location, location!

van Vlodrop IJ, Niessen HE, Derks S, Baldewijns MM, van Criekinge W, Herman JG, van Engeland M.

Clin Cancer Res. 2011 Jul 1;17(13):4225-31. doi: 10.1158/1078-0432.CCR-10-3394. Epub 2011 May 10.

20.

Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.

Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X, Ahmed S, Konishi K, Hamilton SR, Issa JP.

Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18654-9. Epub 2007 Nov 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk